Horvat Natally, Ryan Davinia E, LaGratta Maria D, Shah Pari M, Do Richard Kinh
Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Radiology, Hospital Sírio-Libanês, Sao Paulo, Brazil.
Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Chin Clin Oncol. 2017 Dec;6(6):62. doi: 10.21037/cco.2017.11.03.
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers worldwide due to its aggressiveness and the challenge to early diagnosis. Complete surgical resection is the only curative option, but fewer than 20% of patients have potentially resectable disease at the time of the diagnosis. Radiologists can assess whether PDAC is resectable, borderline resectable, locally advanced or metastatic based on current imaging tests. This review will outline the role of imaging in both the diagnosis and staging of PDAC, with the goal of assisting the multidisciplinary team in tailoring the best treatment for patients.
胰腺导管腺癌（PDAC）因其侵袭性和早期诊断的挑战性，是全球最致命的癌症之一。完整的手术切除是唯一的治愈选择，但在诊断时只有不到20%的患者有潜在可切除的疾病。放射科医生可以根据当前的影像学检查评估PDAC是可切除、边界可切除、局部晚期还是转移性的。本综述将概述影像学在PDAC诊断和分期中的作用，目的是协助多学科团队为患者制定最佳治疗方案。
